NCT01500655

Brief Summary

The purpose of this study is to determine whether either a peripheral nerve block under ultrasound (u/s) guidance of the lateral femoral cutaneous nerve (LFCN), versus an u/s guided block of the nerve followed by continuous catheter infusion of local anesthetic, offers better post-operative analgesia in pediatric burn patients undergoing reconstructive surgery, than the current analgesic regimen of subcutaneous local anesthetic infiltration. Eligible subject, pediatric patients having reconstructive surgery for burns, having skin graft donor sites of the lateral thighs, will be randomized into three groups: control (having local infiltration of site), ultrasound guided nerve block, or ultrasound guided nerve block with catheter placement --fascia iliac. Post-operative comfort will be assessed over the next 48 hours.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

December 23, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 28, 2011

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2013

Completed
Last Updated

December 6, 2016

Status Verified

December 1, 2016

Enrollment Period

5.3 years

First QC Date

December 23, 2011

Last Update Submit

December 5, 2016

Conditions

Keywords

burnskin graft donor siteanalgesia for donor site

Outcome Measures

Primary Outcomes (1)

  • Visual Analog Pain Scale

    We will assess a VAS of pain (0-10)--every 4 hours postoperatively while the patient is awake, for 48 hours post-op.

    Q4 hours,while awake, for 48 hours

Secondary Outcomes (1)

  • Narcotic use

    48 hours postoperative

Study Arms (3)

Catheter

EXPERIMENTAL

An ultrasound guided block of the LFCN is performed, followed by the placement of a catheter underneath the fascia iliaca.

Procedure: Regional nerve blockProcedure: Catheter

Ultrasound guided LFCN block

EXPERIMENTAL

An ultrasound guided regional nerve block --using ropivacaine 0.2%-- will be performed around the lateral femoral cutaneous nerve (LFCN).

Procedure: Regional nerve block

Control

NO INTERVENTION

This group gets the current standard of care--the donor site is infiltrated with 0.25% bupivacaine.

Interventions

a block of the lateral femoral cutaneous nerve is performed under ultrasound guidance. For LFCN block, ropivacaine 0.2% will be used. Dose will be 20 ml, unless patient weighs less than 20 kg, in which case volume will be equal to patient's weight in kilograms.

CatheterUltrasound guided LFCN block
CatheterPROCEDURE

After an ultrasound guided nerve block is performed a catheter is placed under the fascia iliaca and an infusion of ropivacaine 0.2% running at 0.15 ml/kg/hour is administered for 48 hours.

Catheter

Eligibility Criteria

Age2 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • going for reconstructive surgery requiring split thickness skin graft
  • patient's donor site will be in distribution of lateral femoral cutaneous nerve
  • age \>=2 and \<22
  • patient emotionally/intellectually able to describe intensity of post-op pain using VAS or Wong- Baker faces scale.

You may not qualify if:

  • potential block/catheter site infected or burned.
  • intolerance/allergy to local anesthetics
  • BMI \> 30
  • American Society of Anesthesiologists (ASA) score \> 2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shriners Hospital for Children

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Burns

Interventions

Catheters

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • Erik S Shank, MD

    Partners Health Care

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician: Pediatric Anesthesiologist

Study Record Dates

First Submitted

December 23, 2011

First Posted

December 28, 2011

Study Start

April 1, 2008

Primary Completion

July 1, 2013

Study Completion

September 1, 2013

Last Updated

December 6, 2016

Record last verified: 2016-12

Locations